Recommended Pages at cardiab.com
Cardiovascular Diabetology | Abstract | Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: a cross-sectional study
cardiab.com — “Obstructive sleep apnea (OSA) is a common yet underdiagnosed condition. The aim of our study is to test whether prediabetes and type 2 diabetes are associated with obstructive sleep apnea (OSA) in extremely obese (BMI [greater than or equal to] 40 kg/m2) subjects.” View full resource at cardiab.com
Most Recently Shared on October 5, 2011 at 9:40 pm By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Type 2 #diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects. http://t.co/lw2ufCdN
Cardiovascular Diabetology - Latest Articles
cardiab.com — “Cardiovascular Diabetology - Latest Articles” View full resource at cardiab.com
Most Recently Shared on September 10, 2011 at 8:49 am By:
CVD: Effects of calcium channel blockers on glucose tolerance, inflammatory state, http://t.co/Kh7GYiB Full http://t.co/gitwFmU
Cardiovascular Diabetology | Abstract | Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus
cardiab.com — “Cardiovascular disease (CVD) is frequent in type 2 diabetes mellitus patients due to accelerated atherosclerosis. Plasma osteoprotegerin (OPG) has evolved as a biomarker for CVD. We examined the relationship between plasma OPG levels and different CVD manifestations in type 2 diabetes.” View full resource at cardiab.com
Most Recently Shared on August 12, 2011 at 10:12 pm By:
Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in ... http://t.co/mdMQ7k1
Cardiovascular Diabetology | Abstract | Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria
cardiab.com — “Cardiovascular Diabetology | Abstract | Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria” View full resource at cardiab.com
Most Recently Shared on August 10, 2011 at 5:17 am By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Elevated osteoprotegerin is an independent predictor of CAD in diabetic patients with microalbuminuria. http://bit.ly/oehsf2
Cardiovascular Diabetology | Abstract | NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary
cardiab.com — “Intensive multifactorial treatment aimed at cardiovascular (CV) risk factor reduction in type 2 diabetic patients with microalbuminuria can diminish fatal and non-fatal CV. Plasma N-terminal (NT)-proBNP predicts CV mortality in diabetic patients but the utility of P-NT-proBNP in screening for atherosclerosis is unclear. We examined the interrelationship between P-NT-proBNP, presence of atherosclerosis and/or vascular dysfunction in the coronary, carotid and peripheral arteries in asymptomatic ty” View full resource at cardiab.com
Most Recently Shared on August 10, 2011 at 5:10 am By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Half of asymptomatic patients with type 2 #diabetes mellitus and microalbuminuria has significant atherosclerosis. http://bit.ly/qVGp9b
Cardiovascular Diabetology | Abstract | Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes
cardiab.com — “Cardiovascular Diabetology | Abstract | Serum uric acid level and its association with metabolic syndrome and carotid atherosclerosis in patients with type 2 diabetes” View full resource at cardiab.com
Most Recently Shared on August 4, 2011 at 1:03 pm By:
James Underberg Internist, Physician, and Doctor
Serum #UricAcid level association with #MetabolicSyndrome & #carotid #atherosclerosis in type2 #diabetes http://bit.ly/nH8ugb #fb
Cardiovascular Diabetology | Abstract | Impaired fasting glucose is associated with increased perioperative cardiovascular event rates in patients undergoing major non-cardiothoracic surgery
cardiab.com — “Diabetes mellitus (DM) is a well-established risk factor for perioperative cardiovascular morbidity and mortality in patients undergoing noncardiac surgery. However, the impact of preoperative glucose levels on perioperative cardiovascular outcomes in patients undergoing nonemergent, major noncardiothoracic surgery is unclear.” View full resource at cardiab.com
Most Recently Shared on July 14, 2011 at 11:39 am By:
James Underberg Internist, Physician, and Doctor
Impaired fasting glucose: increased perioperative CVD event rates in patients undergoing major non-cardiac surgery http://bit.ly/ngLpau #fb
Cardiovascular Diabetology | Abstract | Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins
cardiab.com — “Cardiovascular disease (CVD) risk in type 2 diabetes (T2DM) is only partially reduced by intensive glycemic control. Diabetic dyslipidemia is suggested to be an additional important contributor to CVD risk in T2DM. Multiple lipid lowering medications effectively reduce fasting LDL cholesterol and triglycerides concentrations and several of them routinely reduce CVD risk. However, in contemporary Western societies the vasculature is commonly exposed to prolonged postprandial hyperlipidemia. Metab” View full resource at cardiab.com
Most Recently Shared on July 9, 2011 at 9:44 pm By:
Postprandial hyperlipidemia, endothelial dysfunction and cardiovascular risk: focus on incretins http://bit.ly/qUDR55
Cardiovascular Diabetology | Abstract | Association between fasting plasma glucose and high-sensitivity C-reactive protein: gender differences in a Japanese community-dwelling population
cardiab.com — “High sensitivity C-reactive protein (hsCRP) is an acute phase reactant and a sensitive marker of inflammation. Hyperglycemia can potentially promote the production of CRP. The aim of this study was to determine whether increased fasting plasma glucose (FPG) levels are associated with elevated hsCRP concentrations by gender.” View full resource at cardiab.com
Most Recently Shared on July 9, 2011 at 4:55 am By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Association between fasting plasma glucose and high-sensitivity C-reactive protein. http://bit.ly/nxF5cR
Cardiovascular Diabetology | Abstract | A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels
cardiab.com — “Cardiovascular Diabetology | Abstract | A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels” View full resource at cardiab.com
Most Recently Shared on June 24, 2011 at 8:55 pm By:
James Underberg Internist, Physician, and Doctor
A progressive increase in CV risk assessed by coronary angiography in non-diabetics at sub-diabetic glucose levels http://bit.ly/lfLm7o
Cardiovascular Diabetology - Latest Articles
cardiab.com — “Cardiovascular Diabetology - Latest Articles” View full resource at cardiab.com
Most Recently Shared on June 2, 2011 at 4:44 pm By:
CVD: Protein Kinase C inhibition ameliorates functional endothelial insulin resistance http://bit.ly/knE6zp Full http://bit.ly/4nbmHK
Cardiovascular Diabetology | Full text | Screening for left ventricular hypertrophy in patients with type 2 diabetes mellitus in the community
cardiab.com — “Left ventricular hypertrophy (LVH) is a strong predictor of cardiovascular disease and is common among patients with type 2 diabetes. However, no systematic screening for LVH is currently recommended for patients with type 2 diabetes. The purpose of this study was to determine whether NT-proBNP was superior to 12-lead electrocardiography (ECG) for detection of LVH in patients with type 2 diabetes.” View full resource at cardiab.com
Most Recently Shared on May 19, 2011 at 3:49 am By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Difficult in primairy care to detect LVH is highly prevalent in asymptomatic patients with #diabetes: http://bit.ly/lqzlwR
Cardiovascular Diabetology | Abstract | Heart-Type Fatty Acid Binding Protein (H-FABP): Relationship with Arterial Intima-Media Thickness and Role as Diagnostic Marker for Atherosclerosis in Patients with Impaired Glucose Metabolism;
cardiab.com — “Heart type fatty acid binding protein (H-FABP ) has been closely associated with acute coronary syndrome, cardiac abnormalities, stroke, and obstructive sleep disorder in previous studies. The aim of this study was to evaluate and compare the serum H-FABP levels and carotid artery intima-media thickness (CIMT) between patients with prediabetes and control subjects.” View full resource at cardiab.com
Most Recently Shared on May 2, 2011 at 8:30 pm By:
Heart-Type Fatty Acid Binding Protein (Cardiovascular Diabetology) http://bit.ly/mw8PjM
Cardiovascular Diabetology | Abstract | Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008
cardiab.com — “For patients with diabetes, clinical practice guidelines recommend treating to a low-density lipoprotein cholesterol (LDL-C) goal of <2.59 mmol/L (100 mg/dL) and a blood pressure (BP) target of <130/80 mmHg. This analysis assessed recent trends in the utilization of lipid-lowering and BP-lowering agents, as well as LDL-C and BP goal attainment, in the U.S. adult diabetic population.” View full resource at cardiab.com
Most Recently Shared on May 2, 2011 at 5:01 am By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Nearly one-half of all U.S. adults with #diabetes are not at recommended LDL-C or BP treatment goals: http://bit.ly/k63v57
Cardiovascular Diabetology | Abstract | Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes
cardiab.com — “Increased fasting plasma glucose (FPG), which includes impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and diabetes, is a risk factor for arterial stiffness. While IFG is widely accepted as a cardiovascular risk factor, recent studies have argued that subjects with high-normal glucose level were characterized by a high incidence of cardiovascular disease. The purpose of this study is to investigate the relationship between FPG and arterial stiffness in non-diabetic healthy subj” View full resource at cardiab.com
Most Recently Shared on May 2, 2011 at 4:57 am By:
Yvo Sijpkens MD Physician, Doctor, Internist, and Nephrologist
Increased arterial stiffness in healthy subjects with high-normal glucose levels: http://bit.ly/kJuZ5V
